CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies
Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD) characterized by disruption of normal mineral homeostasis within the body. One or more of the following may occur: hypocalcemia, hyperphosphatemia, secondary hyperparathyroidism (SHPT), decreased vitamin D and vascular calcification (VC). The greater the decrease in renal function, the worse the progression of CKD-MBD. These abnormalities may lead to bone loss, osteoporosis and fractures. CKD-MBD is a major contributor to the high morbidity and mortality among patients with CKD.
Source: Atherosclerosis - Category: Cardiology Authors: Allison B. Reiss, Nobuyuki Miyawaki, Jane Moon, Lora J. Kasselman, Iryna Voloshyna, Robert D'Avino, Joshua De Leon Tags: Review article Source Type: research
More News: Chronic Kidney Disease | Hyperparathyroidism | Orthopaedics | Osteoporosis | Urology & Nephrology | Vitamin D | Vitamins